Skip to main content
. 2023 Feb 10;23:138. doi: 10.1186/s12885-023-10559-1

Fig. 7.

Fig. 7

Palbociclib resensitizes TamS rGDNF treated cells to TAM. Cell viability assay shows TamS rGDNF treated cells are inhibited by Palbociclib and further inhibited by the combination of Palbociclib and TAM. One way ANOVA was used for statistical analyses. Data are represented as mean ±SEM. * p < 0.01; ** p < 0.0005; *** p < 0.00005